Extension of our EBV-diagnostics by the Anti-EA IgG (Early Antigen)

Extension of our EBV-diagnostics by the Anti-EA IgG (Early Antigen)

• additional detection of the Anti-EA IgG (Early Antigen) without additional costs when testing for EBV antibodies

• helps to distinguish the different stages of the disease (for example acute or past infection).
• IgG antibodies against early antigen appear a little later than the viral-capsid antigen (VCA) in the acute stage.
• their number decreases to non-detectable concentrations after 3-6 months
• generally one should simultaneously test for the current cellular activity by the EBV-EliSpot

An interpretation of possible constellations in a result can be found under "Download our Newsletter"